|
|
Volumn 21, Issue 4, 2015, Pages 293-295
|
|
Facing the challenges of new melanoma-targeted therapies: Treatment of severe fevers associated with dabrafenib/trametinib combination therapy
|
|
Author keywords
BRAF inhibitor; dabrafenib; Melanoma; pyrexia; trametinib
|
|
Indexed keywords
B RAF KINASE;
CEFEPIME;
DABRAFENIB;
DIGOXIN;
OMEPRAZOLE;
PARACETAMOL;
PREDNISOLONE;
ROSUVASTATIN;
TELMISARTAN;
TRAMETINIB;
ANTINEOPLASTIC AGENT;
CEPHALOSPORIN DERIVATIVE;
IMIDAZOLE DERIVATIVE;
OXIME;
PYRIDONE DERIVATIVE;
PYRIMIDINONE DERIVATIVE;
AGED;
ARTICLE;
BODY TEMPERATURE;
CASE REPORT;
CAUCASIAN;
CHILL;
CONFUSION;
CONSULTATION;
DYSLIPIDEMIA;
EMERGENCY WARD;
FEMALE;
FEVER;
GENE MUTATION;
HOSPITAL ADMISSION;
HUMAN;
HYPERTENSION;
LEUKOCYTE COUNT;
MEDICAL HISTORY;
METASTATIC MELANOMA;
NAUSEA;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PAROXYSMAL ATRIAL FIBRILLATION;
PENICILLIN ALLERGY;
PRIORITY JOURNAL;
RIGOR;
THORAX RADIOGRAPHY;
ADVERSE EFFECTS;
CHEMICALLY INDUCED;
DRUG DELIVERY SYSTEM;
MELANOMA;
SEVERITY OF ILLNESS INDEX;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CEPHALOSPORINS;
DRUG DELIVERY SYSTEMS;
FEMALE;
FEVER;
HUMANS;
IMIDAZOLES;
MELANOMA;
OXIMES;
PYRIDONES;
PYRIMIDINONES;
SEVERITY OF ILLNESS INDEX;
|
|
EID: 84936998748
PISSN: 10781552
EISSN: 1477092X
Source Type: Journal
DOI: 10.1177/1078155214527859 Document Type: Article |
|
Times cited : (7)
|
|
References (9)
|
